• Citer

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial

par Maertens, Johan;Aoun, Michel ;Baddley, John J.W.;Giladi, Michael;Heinz, Werner W.J.;Herbrecht, Raoul;Hope, William;Karthaus, Meinolf;Lee, Dong Gun;Lortholary, Olivier;Morrison, Vicki Anne;Raad, Issam Issam;Oren, Ilana;Selleslag, Dominik;Shoham, Shmuel;Thompson, George Richard;Lee, Misun;Maher, Rochelle R.M.;Schmitt-Hoffmann, Anne Hortense;Zeiher, Bernhardt;Ullmann, Andrew;Marr, Kieren K.A.;Patterson, Thomas Frost;Kontoyiannis, Dimitrios D.P.;Cornely, Oliver A;Bow, Eric James;Rahav, Galia;Neofytos, Dionysios
Référence Lancet, 387, 10020, page (760-769)
Publication Publié, 2016-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial
Auteur:	Maertens, Johan; Aoun, Michel; Baddley, John J.W.; Giladi, Michael; Heinz, Werner W.J.; Herbrecht, Raoul; Hope, William; Karthaus, Meinolf; Lee, Dong Gun; Lortholary, Olivier; Morrison, Vicki Anne; Raad, Issam Issam; Oren, Ilana; Selleslag, Dominik; Shoham, Shmuel; Thompson, George Richard; Lee, Misun; Maher, Rochelle R.M.; Schmitt-Hoffmann, Anne Hortense; Zeiher, Bernhardt; Ullmann, Andrew; Marr, Kieren K.A.; Patterson, Thomas Frost; Kontoyiannis, Dimitrios D.P.; Cornely, Oliver A; Bow, Eric James; Rahav, Galia; Neofytos, Dionysios
Informations sur la publication:	Lancet, 387, 10020, page (760-769)
Statut de publication:	Publié, 2016-02
Sujet CREF:	Sciences bio-médicales et agricoles
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0140-6736
	info:doi/10.1016/S0140-6736(15)01159-9
	info:pii/S0140673615011599
	info:scp/84959108062
	info:pmid/26684607